T-cells engineered to recognise tumours expressing the CD30 protein marker
Researchers have genetically engineered immune cells to recognise and fight Hodgkin and non-Hodgkin lymphoma cells...
List view / Grid view
Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer.
Researchers have genetically engineered immune cells to recognise and fight Hodgkin and non-Hodgkin lymphoma cells...
Nanoscientists have identified genes that link to dementia, in the hope that future therapies could target these genes for positive results in patients...
Manchester University researchers have developed a high-throughput platform to analyse and study a family of enzymes that are linked to cancer...
Circulating cell-free DNA (cfDNA) has been shown to have potential as a noninvasive substrate for the detection and monitoring of tumour cells. As circulating tumour DNA is often present at low frequencies within cfDNA, targeted sequencing is an optimal tool for mutation detection.
A recently discovered enzyme could lead to the development of a treatment where cancer cells are starved of 'food' provided by this protein...
Laura Kilpatrick, Chloe Peach and Carl White from the University of Nottingham talk about cancer research and how they use our microplate readers PHERAstar and CLARIOstar.
Mouse models used to show how convection enhanced delivery caused glioma cells to invade the rest of the brain could help to prevent this spread in future...
War On Cancer 2018 discussed how cancer treatments have evolved over the last few decades, and looked at the future of cancer therapies...
Scientists have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells...
Team of oncology experts expand data in Tumor Model Compendium and present strong portfolio at industry conferences...
RIP1 has been shown to suppress the action of macrophages against the immune system and could be a potential therapeutic target for pancreatic cancer...
An experimental cancer vaccine that boosts the immune system's ability to fight cancers could work in tandem with other cancer therapies to fight aggressive tumours, scientists have reported...
A team of researchers have developed a way that could enhance the effect of current antibiotics, using a small molecular attachment called r8...
Brazilian researchers have discovered that a drug widely used as for chemotherapy also acts as an immune response modulator...
Scientists in the U.S. have developed molecules, termed cyclic peptoids, that block the action of genes that drive the growth of therapy-resistant prostate cancer, according to a new study.